H1 Hip Resurfacing Arthroplasty

计划入组 250 人 · 首次发布于 2017 年 10 月 31 日

Dietary Histone Deacetylase Inhibitors (HDAC)

计划入组 23 人 · 首次发布于 2012 年 3 月 2 日

Evaluation of the Omission of Dexamethasone in Premedication Regimens During Paclitaxel Treatment

计划入组 500 人 · 首次发布于 2023 年 11 月 7 日

Recombinant human histone H1.3

Histone H1 inhibitors( Neurocrine Biosciences, Inc.)

CEB-H1

Western History Collection

United States

CSTONE PHARMA-B

Hong Kong, China

Reistone Biopharma Company Limited

China

Santersus Receives Second FDA Breakthrough Device Designation for NucleoCapture in Systemic Lupus Erythematosus

Terumo BCT Partners with Santersus to Advance Novel Blood Purification Technology for Sepsis Treatment

Onchilles Pharma Receives FDA Clearance for First-in-Class ELANE Pathway Cancer Therapeutic N17350